Literature DB >> 12673562

Light chain crystal deposition as a manifestation of plasma cell dyscrasias: the role of immunoelectron microscopy.

Xin Gu1, Roberto Barrios, Joiner Cartwright, Ramon L Font, Luan Truong, Guillermo A Herrera.   

Abstract

Light chain crystal deposition disease is a rare and poorly characterized entity that can be confused with a number of different conditions, depending on where the disease process is manifested. The present study explored the role of ultrastructural immunogold labeling in the diagnosis of this condition. Seven cases of light chain crystal deposition (kappa light chain-related) are reported. Immunohistochemistry and immunofluorescence techniques play a rather limited role in the evaluation of these cases, as a result of the inability to detect monoclonal kappa light chains in association with the crystalline structures or high background staining. Ultrastructural labeling is the method of choice to fully characterize these cases. However, surgical pathologists must learn to recognize the findings associated with this condition to avoid misdiagnosis. If the diagnosis is at least suspected, then a complete hematologic workup may identify the underlying plasma cell dyscrasia. It must be emphasized that in some patients the plasma cell dyscrasia does not become clinically manifested until years after the diagnosis of light chain crystal deposition. Copyright 2003 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673562     DOI: 10.1053/hupa.2003.27

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  7 in total

1.  Current anti-myeloma therapies in renal manifestations of monoclonal light chain-associated Fanconi syndrome: a retrospective series of 49 patients.

Authors:  M Vignon; V Javaugue; M P Alexander; K El-Karoui; A Karras; D Roos-Weil; B Royer; B Asli; B Knebelmann; G Touchard; A Jaccard; B Arnulf; F Bridoux; N Leung; J P Fermand
Journal:  Leukemia       Date:  2016-07-20       Impact factor: 11.528

2.  Systemic and rapidly progressive light-chain deposition disease initially presenting as tubulointerstitial nephritis.

Authors:  Satoko Takahashi; Jun Soma; Izaya Nakaya; Mayumi Yahata; Tsutomu Sakuma; Hiroshi Yaegashi; Akiyoshi Sato; Masaharu Wano; Hiroshi Sato
Journal:  CEN Case Rep       Date:  2012-07-19

3.  Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions.

Authors:  Toshiki Yamada; Yasuhito Nannya; Naoki Mita; Masahito Shimizu; Mitsuru Seishima; Hisashi Tsurumi
Journal:  Int J Hematol       Date:  2016-03-16       Impact factor: 2.490

4.  Crystalline plasma cell inclusions in helicobacter-associated gastritis.

Authors:  C J R Stewart; D V Spagnolo
Journal:  J Clin Pathol       Date:  2006-03-14       Impact factor: 3.411

5.  A case of bilateral renal arterial thrombosis associated with cryocrystalglobulinaemia.

Authors:  Nelson Leung; Francis K Buadi; Kevin W Song; Alexander B Magil; Lynn D Cornell
Journal:  NDT Plus       Date:  2009-09-24

6.  Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.

Authors:  Chung-Kuan Wu; An-Hang Yang; Hung-Chih Lai; Bing-Shi Lin
Journal:  BMC Nephrol       Date:  2017-05-25       Impact factor: 2.388

7.  Crystalglobulin-associated nephropathy presenting as MGRS in a case of monoclonal B-cell lymphocytosis: a case report.

Authors:  Rajib K Gupta; Lois J Arend; Anupama Bk; Sriram Narsipur; Ramya Bhargava
Journal:  BMC Nephrol       Date:  2020-05-18       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.